Stimulation of 5-HT3 Receptors Inhibits Release of Endogenous Noradrenaline from Hypothalamus

[1]  J. Gidda,et al.  LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity. , 1990, The Journal of pharmacology and experimental therapeutics.

[2]  J. Gordon,et al.  Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers. , 1990, European journal of pharmacology.

[3]  R. Kasser,et al.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study , 1990, Brain Research.

[4]  E. Anderson,et al.  5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons , 1990, Brain Research.

[5]  K. Mine,et al.  The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes. , 1990, The Journal of pharmacology and experimental therapeutics.

[6]  R. Glennon,et al.  5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin. , 1990, Journal of medicinal chemistry.

[7]  S. Speciale,et al.  Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat. , 1990, Endocrinology.

[8]  J. Green,et al.  Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. , 1989, The Journal of pharmacology and experimental therapeutics.

[9]  T. Jessell,et al.  5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. J. Schmidt,et al.  The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine. , 1989, European journal of pharmacology.

[11]  R. North,et al.  5-HT3 receptors are membrane ion channels , 1989, Nature.

[12]  B. Costall,et al.  5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue , 1989, Nature.

[13]  J. Green,et al.  Stimulation of histamine H2 receptor in rat hypothalamus releases endogenous norepinephrine. , 1989, The Journal of pharmacology and experimental therapeutics.

[14]  J. Green,et al.  Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. , 1988, European journal of pharmacology.

[15]  B. Costall,et al.  Identification of 5‐HT3 recognition sites in human brain tissue using [3H]zacopride , 1988, The Journal of pharmacy and pharmacology.

[16]  M. Jackson,et al.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line , 1988, Neuron.

[17]  A Butler,et al.  Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors , 1988, British journal of pharmacology.

[18]  R. Naylor,et al.  Zacopride, a potent 5‐HT3 antagonist , 1988, The Journal of pharmacy and pharmacology.

[19]  B. Costall,et al.  The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist , 1988, British journal of pharmacology.

[20]  D. Hoyer.  Molecular pharmacology and biology of 5-HT1C receptors. , 1988, Trends in pharmacological sciences.

[21]  Gavin Kilpatrick,et al.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.

[22]  J. Gray,et al.  GABAB‐receptor mediated inhibition of potassium‐evoked release of endogenous 5‐hydroxytryptamine from mouse frontal cortex , 1987, British journal of pharmacology.

[23]  G. Sanger,et al.  Increased gut cholinergic activity and antagonism of 5‐hydroxytryptamine M‐receptors by BRL 24924: potential clinical importance of BRL 24924 , 1987, British journal of pharmacology.

[24]  M. B. Tyers,et al.  Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve , 1987, British journal of pharmacology.

[25]  G. Sanger,et al.  Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism , 1986, British journal of pharmacology.

[26]  A. Round,et al.  The depolarizing action of 5‐hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205–930 , 1986, British journal of pharmacology.

[27]  H. Herdon,et al.  Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: Effects of depolarizing stimuli, amphetamine and synthesis inhibition , 1985, Brain Research.

[28]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[29]  G. Engel,et al.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs , 1985, Nature.

[30]  C. Arias,et al.  Stimulation of [3H]γ‐Aminobutyric Acid Release by Calcium Chelators in Synaptosomes , 1984 .

[31]  M. Chesselet,et al.  Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis , 1984, Neuroscience.

[32]  D. Middlemiss,et al.  (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor , 1980, Nature.

[33]  J. Fozard,et al.  Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds. , 1979, European journal of pharmacology.

[34]  P. Molinoff,et al.  The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. , 1977, The Journal of pharmacology and experimental therapeutics.

[35]  A. H. Mulder,et al.  Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. , 1977, European journal of pharmacology.

[36]  L. Martini,et al.  Adrenergic and serotoninergic control of growth hormone secretion in adult male rats. , 1972, Endocrinology.

[37]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[38]  J. Green,et al.  Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. , 1991, The Journal of pharmacology and experimental therapeutics.

[39]  M. Göthert.  Modulation of Transmitter Release by Presynaptic Serotonin Receptors , 1988 .